polydine ointment
fischer pharmaceuticals ltd - povidone-iodine - ointment - povidone-iodine 10 %w/w - povidone-iodine - povidone-iodine - for the disinfection of skin infections , wounds and superficial burns.
polydine vaginal pessaries
fischer pharmaceuticals ltd - povidone-iodine - pessary - povidone-iodine 5 % - povidone-iodine - povidone-iodine - treatment of vaginal infections caused by fungi, trichomonas, bacteria or mixed infections.
polydine solution
fischer pharmaceuticals ltd - povidone-iodine - solution - external - povidone-iodine 10 % - iodine products - antiseptic for use in first aid in wounds, scratches, mild burns. for treatment of skin infections caused by bacteria or fungi. antiseptic vaginal douche.
polydine cleanser
fischer pharmaceuticals ltd - povidone-iodine - solution - external - povidone-iodine 7.5 %w/v - povidone-iodine - povidone-iodine - wound disinfection to prevent skin infections caused by bacteria and fungi, disinfection of infected skin conditions and sidinfection of the hands before medical procedures.
benzyl benzoate application bp
bell sons & co. (druggists) limited gifford house, slaidburn crescent, southport, mersyside pr 9 9al, united kingdom - benzyl benzoate - cutaneous solution - benzyl benzoate 25 % (w/v) - ectoparasiticides, incl. scabicides, insecticides and repellents
probenecid tablet, film coated
physicians total care, inc. - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - for treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.
probenecid tablet
westminster pharmaceuticals, llc - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - for treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.
probenecid tablet, film coated
actavis pharma, inc. - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - for treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.
probenecid and colchicine tablet
ingenus pharmaceuticals, llc - probenecid (unii: po572z7917) (probenecid - unii:po572z7917), colchicine (unii: sml2y3j35t) (colchicine - unii:sml2y3j35t) - for the treatment of chronic gouty arthritis when complicated by frequent, recurrent acute attacks of gout. hypersensitivity to this product or to probenecid or colchicine. probenecid and colchicine tablets are contraindicated in children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid and colchicine should not be started until an acute gouty attack has subsided. pregnancy: probenecid crosses the placental barrier and appears in cord blood. colchicine can arrest cell division in animals and plants. in certain species of animals under certain conditions, colchicine has produced teratogenic effects. the possibility of such effects in humans also has been reported. because of the colchicine component, probenecid and colchicine is contraindicated in pregnant patients. the use of any drug in women of childbearing potential requires that the anticipated benefit be weighed against the possible hazards.
fluorescein sodium and benoxinate hydrochloride solution/ drops
bausch & lomb incorporated - benoxinate hydrochloride (unii: 0ve4u49k15) (benoxinate - unii:axq0jym303), fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir) - benoxinate hydrochloride 4 mg in 1 ml - for procedures requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent such as tonometry, gonioscopy, removal of corneal foreign bodies and other short corneal or conjunctival procedures. known hypersensitivity to any component of this product. prolonged use of a topical ocular anesthetic is not recommended. it may produce permanent corneal opacification with accompanying visual loss.